Licence holders of transplant products

Following the entry into force of the new Therapeutic Products Act (TPA, SR 812.21) and the revised Medicinal Products Licensing Ordinance (MPLO, SR 812.212.1), establishment licences for TPs, GTPs or GMOs granted from 1 January 2019 have been issued under the new legislation. Holders of establishment licences issued under the new legislation appear in the following list: “Establishment licences for TPs, GTPs or GMOs issued under the new legislation”. Establishment licences for TPs, GTPs or GMOs issued pursuant to the old legislation will retain their validity until their expiry date or for five years at the most from 1 January 2019. Holders of establishment licences issued under the old legislation appear in the following list: “Establishment licences for TPs, GTPs or GMOs issued under the old legislation”. During the transitional period lasting until all establishment licences issued under the old legislation and not renewed under the new legislation have expired, it should be borne in mind that a licence holder may appear in either of the two published lists.